280 related articles for article (PubMed ID: 15901797)
21. Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.
Komazin G; Ptak RG; Emmer BT; Townsend LB; Drach JC
J Virol; 2003 Nov; 77(21):11499-506. PubMed ID: 14557635
[TBL] [Abstract][Full Text] [Related]
22. Convergent synthesis of polyhalogenated quinoline C-nucleosides as potential antiviral agents.
Chen JJ; Drach JC; Townsend LB
J Org Chem; 2003 May; 68(11):4170-8. PubMed ID: 12762715
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiviral evaluation of certain disubstituted benzimidazole ribonucleosides.
Zou R; Ayres KR; Drach JC; Townsend LB
J Med Chem; 1996 Aug; 39(18):3477-82. PubMed ID: 8784445
[TBL] [Abstract][Full Text] [Related]
24. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
[TBL] [Abstract][Full Text] [Related]
25. Benzimidazole 2'-isonucleosides: design, synthesis, and antiviral activity of 2-substituted-5,6-dichlorobenzimidazole 2'-isonucleosides.
Freeman GA; Selleseth DW; Rideout JL; Harvey RJ
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):155-74. PubMed ID: 10772707
[TBL] [Abstract][Full Text] [Related]
26. Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells.
Nassiri MR; Emerson SG; Devivar RV; Townsend LB; Drach JC; Taichman RS
Br J Haematol; 1996 May; 93(2):273-9. PubMed ID: 8639416
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy) methyl]- and -1-[(1,3-dihydroxy-2-propoxy) methyl]benzimidazoles.
Saluja S; Zou R; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):881-91. PubMed ID: 8632412
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and antiviral evaluation of some polyhalogenated indole C-nucleosides.
Chen JJ; Wei Y; Williams JD; Drach JC; Townsend LB
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1417-37. PubMed ID: 16438026
[TBL] [Abstract][Full Text] [Related]
29. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56.
Krosky PM; Underwood MR; Turk SR; Feng KW; Jain RK; Ptak RG; Westerman AC; Biron KK; Townsend LB; Drach JC
J Virol; 1998 Jun; 72(6):4721-8. PubMed ID: 9573236
[TBL] [Abstract][Full Text] [Related]
30. A Guinea pig cytomegalovirus resistant to the DNA maturation inhibitor BDCRB.
Ourahmane A; Sauer A; Nixon DE; Murphy C; Mondello M; Douglass Chiu E; Siegmund S; Wang JB; McVoy MA
Antiviral Res; 2018 Jun; 154():44-50. PubMed ID: 29649495
[TBL] [Abstract][Full Text] [Related]
31. Impact of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole riboside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus genome maturation.
McVoy MA; Nixon DE
J Virol; 2005 Sep; 79(17):11115-27. PubMed ID: 16103162
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.
Zacny VL; Gershburg E; Davis MG; Biron KK; Pagano JS
J Virol; 1999 Sep; 73(9):7271-7. PubMed ID: 10438815
[TBL] [Abstract][Full Text] [Related]
33. Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus.
Evers DL; Komazin G; Shin D; Hwang DD; Townsend LB; Drach JC
Antiviral Res; 2002 Oct; 56(1):61-72. PubMed ID: 12323400
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles.
Townsend LB; Devivar RV; Turk SR; Nassiri MR; Drach JC
J Med Chem; 1995 Sep; 38(20):4098-105. PubMed ID: 7562945
[TBL] [Abstract][Full Text] [Related]
35. Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides.
Komazin G; Townsend LB; Drach JC
J Virol; 2004 Jan; 78(2):710-5. PubMed ID: 14694102
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of tricyclic nucleosides (dimensional probes) as analogues of certain antiviral polyhalogenated benzimidazole ribonucleosides.
Zhu Z; Lippa B; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2430-7. PubMed ID: 10882370
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiviral evaluation of trisubstituted indole N-nucleosides as analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole (TCRB).
Chen JJ; Wei Y; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2449-56. PubMed ID: 10882372
[TBL] [Abstract][Full Text] [Related]
38. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
Yang JZ; Chen W; Borchardt RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
[TBL] [Abstract][Full Text] [Related]
39. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
Fu XZ; Jiang SH; Yang YS; Ji RY
Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs.
Yuan H; Li N; Lai Y
Drug Metab Dispos; 2009 Jul; 37(7):1443-7. PubMed ID: 19372225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
